AZN · AstraZeneca PLC
118.92
GBPUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
GBP188.92B
PE
27.50
EV/EBITDA
15.8
DIV Yield
1.7%
Payout Ratio
47%
MQV Rating
4Weak
As at 08/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- ALL-Recommendations
- Consensus Cheap
- HALO 100
- HALO 200
- HALO 50
- HALO All
- HALO Capital Efficiency
- Hammer Bullish (Realtime)
Key Fundamentals
EPS 3 yr Growth
210.60%
EBITDA Margin
33.20%
Operating Cashflow
$14,861m
Free Cash Flow Return
20.50%
ROIC
14.10%
Interest Coverage
14.60
Quick Ratio
0.70
Performance
52 weeks range
Low 105.24 - 154.74
Trade Value (12mth)
US$116,153,588.00
1 week
-0.81%
1 month
4.55%
YTD
-10.39%
1 year
-4.71%
All time high
154.74
Additional Data
Shares Outstanding (Fully Diluted)
1,560m
HALO Sector
Healthcare
Next Company Report Date
11-Feb-27
Next Ex Dividend Date
06-Aug-26
Next Dividend Pay Date
08-Sep-26
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Weak
Garp
Neutral
Mqv Small
Neutral
Momentum
Price
Weak
Earnings
Strong
Growth
Earnings
Neutral
Dividends
Neutral
Quality
Capital Efficiency
Very Strong
Balance Sheet
Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
05 October 26RNS | |
02 October 26RNS | |
02 October 26RNS | |
02 October 26RNS | |
29 September 26RNS |
Key Stakeholders
| Name | Title |
| Investor AB (Investment Company) | Operating Division |
| OrbiMed Advisors Private Equity | Subsidiary |
| Pascal Soriot | Individual |
| Aradhana Sarin | Individual |
| Parkwood LLC | Private Company |
